Raymond James Financial
TECX

Raymond James Financial’s Tectonic Therapeutic TECX Stock Holding History

Raymond James Financial’s Portfolio TECX Stock Details TECX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.98M Buy
64,196
+9,595
+18% +$236K ﹤0.01% 3366
2025
Q4 		$1.14M Buy
54,601
+2,670
+5% +$49.6K ﹤0.01% 3693
2025
Q3 		$815K Buy
51,931
+30,387
+141% +$627K ﹤0.01% 3815
2025
Q2 		$428K Buy
21,544
+2,809
+15% +$56.9K ﹤0.01% 4099
2025
Q1 		$332K Buy
18,735
+13,796
+279% +$450K ﹤0.01% 4156
2024
Q4 		$228K Buy
+4,939
New +$209K ﹤0.01% 4328

Other funds holding TECX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
B
Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return
FLAM
First Light Asset Management Edina, Minnesota $1.12B AUM 114.45% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
VPC
Vestal Point Capital New York $3.58B AUM 189.12% 1-Year Est. Return

Raymond James Financial's TECX Position: Q1 2026 in Review

Raymond James Financial increased its Tectonic Therapeutic (TECX) stake by 18% in Q1 2026, buying an estimated $236K and bringing the position to 64,196 shares worth $1.98M. The position accounts for ﹤0.01% of the portfolio, ranked #3366.

Raymond James Financial first reported a position in TECX in Q4 2024 and has held it in 6 quarters since. 111 funds tracked by Wall St. Rank hold TECX as of Q1 2026.

  • Raymond James Financial held 64,196 shares of Tectonic Therapeutic worth $1.98M as of Q1 2026.
  • Raymond James Financial bought 9,595 Tectonic Therapeutic shares in Q1 2026, an estimated $236K.
  • Tectonic Therapeutic made up ﹤0.01% of Raymond James Financial's portfolio in Q1 2026, its #3366 holding.
  • Raymond James Financial first reported a position in Tectonic Therapeutic in Q4 2024 and has held it in 6 quarters since.
  • 111 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q1 2026.

Based on Raymond James Financial's 13F filing for Q1 2026, filed 14 May 2026.